Serge Saxonov
CEO at 10x Genomics, Inc. (TXG)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $6.8M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 24SEC | TXG10x Genomics, Inc. | Sell Plan | 1,0001,074,249 held (−0%) | $78.23 | $78K | +3.1% |
| Sep 24SEC | TXG10x Genomics, Inc. | Sell Plan | 2,0001,072,249 held (−0%) | $79.62 | $159K | +1.3% |
| Sep 24SEC | TXG10x Genomics, Inc. | Sell Plan | 9,3001,062,949 held (−1%) | $80.90 | $752K | -0.3% |
| Sep 24SEC | TXG10x Genomics, Inc. | Sell Plan | 9,9001,053,049 held (−1%) | $81.83 | $810K | -1.4% |
| Sep 24SEC | TXG10x Genomics, Inc. | Sell Plan | 2,8001,050,249 held (−0%) | $82.37 | $231K | -2.1% |
| Aug 28SEC | TXG10x Genomics, Inc. | Sell Plan | 3,5001,082,335 held (−0%) | $63.02 | $221K | +28.0% |
| Aug 28SEC | TXG10x Genomics, Inc. | Sell Plan | 6,4941,075,841 held (−1%) | $63.98 | $415K | +26.1% |
| Aug 28SEC | TXG10x Genomics, Inc. | Sell Plan | 4921,075,349 held (−0%) | $64.75 | $32K | +24.6% |
| Aug 26SEC | TXG10x Genomics, Inc. | Sell | 18,5451,085,835 held (−2%) | $63.02 | $1.2M | +28.0% |
| Jun 24SEC | TXG10x Genomics, Inc. | Sell Plan | 8,5271,129,853 held (−1%) | $33.29 | $284K | +142.3% |
| Jun 24SEC | TXG10x Genomics, Inc. | Sell Plan | 9,9911,119,862 held (−1%) | $34.28 | $342K | +135.3% |
| Jun 24SEC | TXG10x Genomics, Inc. | Sell Plan | 9,8211,110,041 held (−1%) | $35.32 | $347K | +128.3% |
| Jun 24SEC | TXG10x Genomics, Inc. | Sell Plan | 1,6611,108,380 held (−0%) | $36.16 | $60K | +123.0% |
| May 27SEC | TXG10x Genomics, Inc. | Sell Plan | 18,1751,149,098 held (−2%) | $24.44 | $444K | +230.0% |
| May 27SEC | TXG10x Genomics, Inc. | Sell Plan | 10,7181,138,380 held (−1%) | $24.71 | $265K | +226.4% |
| Apr 16SEC | TXG10x Genomics, Inc. | Sell Plan | 5,0001,167,273 held (−0%) | $24.56 | $123K | +228.4% |
| Mar 25SEC | TXG10x Genomics, Inc. | Sell Plan | 10,0001,177,273 held (−1%) | $19.13 | $191K | +321.6% |
| Mar 25SEC | TXG10x Genomics, Inc. | Sell Plan | 5,0001,172,273 held (−0%) | $19.52 | $98K | +313.2% |
| Mar 4SEC | TXG10x Genomics, Inc. | Sell Plan | 14,2921,205,527 held (−1%) | $22.67 | $324K | +255.8% |
| Mar 4SEC | TXG10x Genomics, Inc. | Sell Plan | 1,8601,203,667 held (−0%) | $23.18 | $43K | +247.9% |
| Feb 25SEC | TXG10x Genomics, Inc. | Sell | 9,6321,061,924 held (−1%) | $18.58 | $179K | +334.1% |
| Nov 25SEC | TXG10x Genomics, Inc. | Sell | 13,2611,021,556 held (−1%) | $19.00 | $252K | +324.5% |
- Sell
CEO Serge Saxonov sold $78K of TXG at $78.23 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Serge Saxonov sold $159K of TXG at $79.62 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Serge Saxonov sold $752K of TXG at $80.90 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Serge Saxonov sold $810K of TXG at $81.83 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Serge Saxonov sold $231K of TXG at $82.37 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Serge Saxonov sold $221K of TXG at $63.02 — pre-scheduled 10b5-1 plan sale.